HHS Casts Doubts On mRNA Products, But Funds Studies On Debunked Theories

It’s conspicuous that HHS refuses to review Moderna’s application for regulatory approval of an mRNA-based flu vaccine while it prioritizes research on debunked theories.

Continue Reading

News Source: www.forbes.com